Keywords: goldshield, acquires, product, licenses, novartis, l6, 5m
Goldshield acquires three product licenses from Novartis for L6.5m
Article | 06 April 2000
Goldshield Group of the UK has acquired three product licensesfrom Novartis Pharmaceuticals UK for L6.5 million ($10.4 million) in cash, payable ...
Enjoying this article? To continue reading you need to login or subscribe.
Subscribe now
for unlimited access to all articles
Subscriptions are £60 per month, pay as you go.
Find out more details.
Already a subscriber? Click here to log in
- US Supreme Court says patent settlement can "sometimes" be illegal
- InSite Vision joins Merck & Co and Pfizer in patent infringement law suit against
- Highlights of EHA meeting: Novartis' Jakavi; Bristol-Myers and AbbVie's elotuzumab; Janssen's ibrutinib
- Daiichi Sankyo files for Japanese approval of Prasugrel
- Osteoporosis drug bazedoxifene stops growth of breast cancer cells, even in resistant tumors
